Five years ago, the phrase “right to try” wasn’t yet an inkling in the minds of its staunchest advocates. Today, the pithy shorthand for the campaign to get dying patients access to experimental treatments has been slapped on bumper stickers, emblazoned on T-shirts, and uttered by some of the most powerful figures in Washington

Quick Read

Federal regulators approved the first direct-to-consumer test for the BRCA genes, which increase the risk of breast and ovarian cancer, the agency announced on Tuesday

Quick Read

The proposal to bring back asylums — in a modern, transparent form — is very much alive for other reasons among some policy experts, psychiatrists and bioethicists. “When people are going back and forth from prisons to hospitals, that’s a sign they might have benefited from longer-term treatment options,” said Dominic Sisti, a medical ethicist at the University of Pennsylvania School of Medicine

Quick Read

Twenty years ago, images of staggering cattle and descriptions of brains resembling Swiss cheese became associated with one of the most popular television programs of the day when Texas Panhandle cattlemen sued “The Oprah Winfrey Show” for defamation under Texas’ “veggie libel law.” They claimed the program’s negative portrayal of their business caused a steep decline of beef prices

Quick Read

A 1996 bill has had a chilling effect on the CDC’s ability to research firearms

Quick Read

First, make sure the FDA stays involved

Quick Read

Jessica Porten went to a women’s clinic in Sacramento, CA that accepts her Medicaid coverage, to talk about medication options and therapy. Porten admitted to the nurse that she was having some violent thoughts. “I described maybe hitting myself or squeezing the baby too tight,” she said. “But I was very adamant through the entire appointment that I was not going to hurt myself and I was not going to hurt my children.”

Quick Read

Dozens of doctors, medical ethicists, and lawyers are warning Congress that legislation to allow Americans with life-threatening conditions access to unapproved, experimental drugs risks harming patients’ health

Quick Read